BD Vacutainer® Plasma Separator Tubes (PST), BD Vacutainer® Sodium Heparin Blood Collection Tubes— 510(k) K252040

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K252040 for BD Vacutainer® Plasma Separator Tubes (PST), BD Vacutainer® Sodium Heparin Blood Collection Tubes, Substantially Equivalent on 2026-03-13. Applicant: Becton, Dickinson and Company. Device class: 2.

Summary

Becton, Dickinson and Company's record covers BD Vacutainer® Plasma Separator Tubes (PST) and BD Vacutainer® Sodium Heparin Blood Collection Tubes. Both are filed under JKA, blood collection tubes, vials, systems and serum separators.

Class II, 21 CFR 862.1675. Clinical Chemistry is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Becton, Dickinson and Company filed from Franklin Lakes, New Jersey. Review took 256 calendar days (June 30, 2025 to March 13, 2026).

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Product code JKA
Device class
Class 2
Regulation
21 CFR 862.1675
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Franklin Lakes, NJ, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code JKA

view all

More clearances from Becton, Dickinson and Company

view all

Adverse events under product code JKA

product code JKA
Injury
455
Malfunction
26,686
Other
4
Total
27,145

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.